Thank you for visiting the Elion Labs website!

Elion was acquired by KBI Biopharma, a leading global CDMO, in January 2018. Since the acquisition, Elion has continued to provide the high-quality analytical services it has offered since its founding in 2015. We look forward to expanding current client relationships, and building new ones, as part of KBI Biopharma. Please contact us below to learn more about how we, as part of KBI, can partner with you to support your analytical needs.